Probiotic Lactobacillus Paracasei Expressing a Nucleic Acid-Hydrolyzing Minibody (3D8 Scfv) Enhances Probiotic Activities in Mice Intestine as Revealed by Metagenomic Analyses.

Probiotics are well known for their beneficial effects for animals, including humans and livestock. Here, we tested the probiotic activity of <italic>Lactobacillus paracasei</italic> expressing 3D8 scFv, a nucleic acid-hydrolyzing mini-antibody, in mice intestine. A total of 18 fecal samples derived from three different conditions at two different time points were subjected to high-throughput 16S ribosomal RNA (rRNA) metagenomic analyses. Bioinformatic analyses identified an average of 290 operational taxonomic units. After administration of <italic>L. paracasei</italic>, populations of the probiotics <italic>L. paracasei</italic>, <italic>Lactobacillus reuteri</italic>, and <italic>Pediococcus acidilactici</italic> increased, whereas the population of harmful bacteria such as <italic>Helicobacter</italic> species decreased. Furthermore, continuous administration of <italic>L. paracasei</italic> resulted in <italic>L. paracasei</italic> emerging as the dominant probiotic after competition with other existing probiotics. Expression of 3D8 scFv protein specifically increased the population of <italic>P. acidilactici</italic>, which is another probiotic. In summary, our results showed that <italic>L. paracasei</italic> expressing 3D8 scFv protein enhanced probiotic activity in mice intestine with no observable side effects. Thus, the system developed in this study may be a good tool for the expression of recombinant protein using probiotics. [ABSTRACT FROM AUTHOR]